Samsung Showcases AI-Based Automatic Measurement and Diagnostic Solutions at ISUOG World Congress 2023

Samsung introduces the premium ultrasound system “HERA W10 Elite” and “V8” and presents a use case of SonoSync™, a real-time ultrasound image-sharing solution

▲ The ISUOG World Congress will be held in Seoul, Korea from October 16 to 19

Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, will be showcasing its AI-based diagnostic solutions at ISUOG (International Society of Ultrasound in Obstetrics and Gynecology) World Congress 2023 held in Seoul, South Korea from October 16 to 19.

As one of the most important academic societies in the field of obstetric and gynecologic ultrasound, ISUOG organizes annual congresses worldwide to share the latest technology and research findings. This year’s event, held for the first time in Seoul, will be attended by nearly 2,000 obstetricians and gynecologists from 126 countries.

Samsung Medison, a main sponsor of the event, will showcase Samsung’s AI diagnostic technology through the display of its premium ultrasound systems “HERA W10 Elite” and “V8,” diagnostic solution demonstrations and a symposium.

▲ Samsung Medison’s HERA W10 Elite(left) and V8 will be exhibited at ISUOG 2023

HERA W10 Elite is a premium ultrasound system equipped with a 27-inch OLED monitor, which exhibits less brightness variation across viewing angles than conventional LCD monitors. Its probe delivers superior resolution, allowing users to view high-contrast ultrasound images from various angles without compromising image quality.

At the conference, Samsung Medison will showcase AI-based diagnostic assistant solutions, including HeartAssist™, which categorizes and provides measurement results for fetal heart diagnosis with a simple press of a button; and UterineAssist™, which automatically measures the size and shape of the uterus helping to accurately examine and diagnose the uterus.

In addition, Samsung Medison will present AI-automated measurement functions such as BiometryAssist™ and ViewAssist™, which measure and automatically annotate fetal growth indicators by extending the items previously measured only in the 2nd trimester (14-27 weeks) to the 1st trimester (1-13 weeks) in accordance with the newly revised ISUOG guidelines in February 2023.

“Using the BiometryAssist™ feature, fetal weight can be measured with professional accuracy up to 48 hours before delivery, and the measurement time can be dramatically reduced,” said Professor Mar Gil of Torrejón University Hospital, Spain, in an abstract of the study available for publication at the conference.

At the conference, Samsung Medison will also introduce an upgraded version of “5D CNS (Central Nervous System)+,” a convenient feature for fetal brain examination.

A positive reception is anticipated at the conference due to its automatic provision of nine essential cross-sections of the fetal brain, including the coronal and sagittal planes and six measurements necessary for diagnosis – head circumference and diameter, with high accuracy.

Other features such as SonoSync™, which specializes in remote consulting and training, and S-Hub™, an IT solution for hospital resource management, will be on display to medical professionals from around the world.

Samsung Medison will hold symposia on “Obstetrics” and “Gynecology” on October 17 and 18, respectively, to present research findings on the clinical utility of features that help diagnose the heart and brain of a fetus and endometriosis.

During the “Fetal Therapy and Telesonography” session in the “Obstetrics” symposium, Dr. Ruben Quintero from The Fetal Institute in the United States will present a case where SonoSync™, a real-time ultrasound image-sharing solution with remote control ability, saved the life of a mother and her newborn in a case of misdiagnosed fetal distress.

In the “Gynecology” symposium, Professor Tom Bourne from Imperial College, U.K., will present his research on ovarian tumors using CrystalVue™ and MV-Flow™ features.

“Samsung is continuously developing AI technologies that improve diagnostic efficiency so that doctors can focus more on patient care,” said Jinyong Lee, Head of the AI Vision Group at Samsung Medison. “We are continually striving to develop technologies that can be utilized in the field of obstetrics and gynecology to contribute to improving maternal and fetal health.”

The conference, which is held for the first time in South Korea, is also the first offline event since the end of the COVID-19 pandemic. Samsung Medison is participating as the main sponsor and engaging in various academic activities, including the Samsung-ISUOG webinars and the Pre-Congress.

▲ ISUOG Industry Webinar schedule

For more information on Samsung’s Healthcare division, its subsidiaries and products please visit www.samsunghealthcare.com.